2. Protein Tyrosine Kinase/RTK Apoptosis
  3. FLT3 Apoptosis
  4. FLT3-IN-32

FLT3-IN-32 is a potent FLT3 inhibitor. FLT3-IN-32 shows high selectivity for FLT3 and efficiently inhibits FLT3-activating mutations and induces apoptosis. FLT3-IN-32 shows good tolerability in non-tumor bearing mice. FLT3-IN-32 demonstrates outstanding anti-tumor efficacy in MV4-11 bearing NOD/SCID mice, prolonging the survival noticeably. FLT3-IN-32 can be used for the research of acute myeloid leukemia.

For research use only. We do not sell to patients.

FLT3-IN-32 Chemical Structure

FLT3-IN-32 Chemical Structure

CAS No. : 3047195-48-9

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

FLT3-IN-32 Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

FLT3-IN-32 is a potent FLT3 inhibitor. FLT3-IN-32 shows high selectivity for FLT3 and efficiently inhibits FLT3-activating mutations and induces apoptosis. FLT3-IN-32 shows good tolerability in non-tumor bearing mice. FLT3-IN-32 demonstrates outstanding anti-tumor efficacy in MV4-11 bearing NOD/SCID mice, prolonging the survival noticeably. FLT3-IN-32 can be used for the research of acute myeloid leukemia[1].

In Vitro

FLT3-IN-32 (Compound 29c) (0.3-218.7 nM, 72 h) effectively inhibits the proliferation in four different Ba/F3 cell lines expressing mutant FLT3 isoforms[1].

FLT3-IN-32 shows promising (1 μM-1 M) selectivity and safety toward FLT3-ITD-positive cells[1].

FLT3-IN-32 (100-500 nM, 48 h) induces apoptosis in four different Ba/F3 cell lines expressing mutant FLT3 isoforms[1].

FLT3-IN-32 (1-50 nM, 4 h) decreases the levels of phosphorylation of FLT3 and its downstream signaling molecules (STAT5, MAPK)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

FLT3-IN-32 Related Antibodies

Cell Proliferation Assay[1]

Cell Line: Ba/F3 pMIY FLT3-ITD (NPOS), Ba/F3 pMIY FLT3 D835Y, Ba/F3 pMIY FLT3 NPOS D835Y, Ba/F3 pMIY FLT3 NPOS N 676K cells
Concentration: 0.3-218.7 nM
Incubation Time: 72 h
Result: Showed effectively inhibition with IC50 values of 0.29 nM, 0.77 nM, 11.69 nM and 2.07nM, respectively.

Apoptosis Analysis[1]

Cell Line: Ba/F3 pMIY FLT3-ITD (NPOS), Ba/F3 pMIY FLT3 D835Y, Ba/F3 pMIY FLT3 NPOS D835Y, Ba/F3 pMIY FLT3 NPOS N 676K cells
Concentration: 5, 20, 100,and 500 nM
Incubation Time: 48 h
Result: Showed highly potent in inducing apoptotsis in FLT3 D835Y cells (54.11 %) and FLT3 NPOS N676K cells (38.43 %) at 100 nM.

Cell Proliferation Assay[1]

Cell Line: Ba/F3 pMIY FLT3-ITD (NPOS) cells
Concentration: 1, 5, 10, 20, and 50 nM
Incubation Time: 4 h
Result: Decreased the levels of phosphorylation of FLT3 and its downstream signaling molecules including STAT5, MAPK and to a lesser extent also AKT in a concentration-dependent manner.
In Vivo

FLT3-IN-32 (Compound 29c) (50 mg/kg, p.o., daily for 5 days) shows effectively tumor inhibition MV4-11 CDX (cell-line derived xenograft) model in non-tumor bearing NOD/SCID mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MV4-11 CDX (cell-line derived xenograft) model in non-tumor bearing NOD/SCID mice (female, 8-9 weeks)[1]
Dosage: 50 mg/kg
Administration: Oral administration, daily for 5 days
Result: Showed less relative body weight loss compared to Quizartinib (HY-13001) and comparable with Midostaurin (HY-10230).
Showed similarly inhibitive activity as Quizartinib (HY-13001) and much more active than Midostaurin (HY-10230).
Animal Model: Non-tumor bearing NOD/SCID mice (female, 6-8 weeks)[1]
Dosage: 20, 50, 75 mg/kg
Administration: Oral administration, Intraperitoneal injection (20, 50 mg/kg), 15 days
Result: Showed good tolerability.
Molecular Weight

515.56

Formula

C28H29N5O5
CAS No.
SMILES

O=C(NC1=CC=C(OC(C(C(N2)=CC3=C2C=CC(O)=C3CN(C)C)=O)=C4)C4=C1)NC5=NOC(C(C)(C)C)=C5
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

FLT3-IN-32 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

FLT3-IN-323047195-48-9FLT3ApoptosisCluster of differentiation antigen 135CD135Fms like tyrosine kinase 3Acute myeloid leukemiaFMS-like tyrosine kinase (FLT3)MV4-11 cellsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
FLT3-IN-32
Cat. No.:
HY-174437
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.